Boston Scientific Corporation (BSX) vs McKesson Corporation (MCK)
A side-by-side comparison of Boston Scientific Corporation and McKesson Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 3, 2026. Differences are shown without an overall score or investment verdict.
BSX
Boston Scientific Corporation
$47.60HealthcareDelayed quote: Aug 3, 2026, 11:10 AM EDT
MCK
McKesson Corporation
$852.35HealthcareDelayed quote: Aug 3, 2026, 11:10 AM EDT
Total return — BSX vs MCK
growth of $100 · dividends reinvested · last 30yBSX +318.9%MCK +4961.3%MCK compounded faster
Log scale — wide-divergence pair
BSX MCK
BSX vs MCK: by the numbers
- •MCK is the larger company ($99.79B vs $70.75B market cap).
- •BSX trades at the lower trailing earnings multiple (19.00 vs 22.26 P/E), one valuation lens rather than an overall verdict.
- •BSX converts more revenue to profit (17.47% vs 1.18% net margin).
- •BSX grew revenue faster over the past five years (13.40% vs 11.11% CAGR).
- •MCK pays a dividend (0.38% yield), while BSX has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | BSX | MCK |
|---|---|---|
| P/E ratio | 19.00 | 22.26 |
| Forward P/E | 14.15 | 21.95 |
| P/S ratio | 3.30 | 0.26 |
| P/B ratio | 2.70 | N/A |
| PEG ratio | 0.88 | 0.46 |
| EV / EBITDA | 14.14 | 15.45 |
| FCF yield | 4.93% | 5.65% |
Profitability
| Metric | BSX | MCK |
|---|---|---|
| Gross margin | 71.16% | 3.61% |
| Operating margin | 21.46% | 1.58% |
| Net margin | 17.47% | 1.18% |
| ROE | 14.18% | -219.24% |
| ROIC | 8.78% | 31.48% |
Dividends
| Metric | BSX | MCK |
|---|---|---|
| Dividend yield | N/A | 0.38% |
| Payout ratio | N/A | 8.51% |
Growth (annualized)
| Metric | BSX | MCK |
|---|---|---|
| Revenue CAGR (5Y) | 13.40% | 11.11% |
| EPS CAGR (5Y) | N/A | 40.71% |
| FCF CAGR (5Y) | 19.89% | 8.76% |
| Total return CAGR (5Y) | 0.49% | 33.96% |
Frequently asked
- Which has the lower trailing P/E, BSX or MCK?
- BSX has the lower trailing P/E: BSX trades at 19.00 and MCK at 22.26. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, BSX or MCK?
- Over the past five years, BSX grew revenue faster — BSX at a 13.40% CAGR versus MCK at 11.11%.
- Does BSX or MCK pay a bigger dividend?
- MCK pays a dividend (0.38% yield), while BSX has no payments in the available dividend history.
- Is BSX or MCK more profitable?
- BSX runs the higher net margin — BSX at 17.47% versus MCK at 1.18%.
- How have BSX and MCK total returns compared?
- Over the past 10 years, BSX delivered 6.76% and MCK delivered 16.86% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Boston Scientific P/E ratioMcKesson P/E ratioBoston Scientific dividend yieldMcKesson dividend yieldBoston Scientific ROEMcKesson ROEBoston Scientific operating marginMcKesson operating marginBoston Scientific revenue growthMcKesson revenue growthBoston Scientific free cash flowMcKesson free cash flow
Boston Scientific & McKesson appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 3, 2026.